Release Date: 2023-09-14

Sleep Disorders in Diabetes Mellitus

Mustafa Karaagac (Author)

Release Date: 2023-09-14

Sleep disorders in individuals with diabetes mellitus are a significant concern due to their bidirectional relationship, impacting both diabetes management and overall health. Many diabetic patients experience disturbances such as obstructive sleep apnea (OSA), insomnia, restless legs syndrome (RLS), and alterations in sleep architecture. OSA, often prevalent in diabetics, exacerbates insulin resistance and glucose intolerance [...]

Media Type

  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inCurrent Perspective on Diabetes Mellitus in Clinical Sciences
First Page363
Last Page370
DOIhttps://doi.org/10.69860/nobel.9786053359111.34
ISBN978-605-335-911-1 (PDF)
LanguageENG
Page Count8
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

Sleep disorders in individuals with diabetes mellitus are a significant concern due to their bidirectional relationship, impacting both diabetes management and overall health. Many diabetic patients experience disturbances such as obstructive sleep apnea (OSA), insomnia, restless legs syndrome (RLS), and alterations in sleep architecture. OSA, often prevalent in diabetics, exacerbates insulin resistance and glucose intolerance through intermittent hypoxia and sleep fragmentation. Insomnia, another common issue, can worsen glycemic control and increase the risk of diabetic complications. RLS affects sleep quality and is associated with higher insulin resistance and prevalence in diabetic populations. Moreover, diabetes-related neuropathy can lead to painful sleep disturbances. Addressing these sleep disorders requires a multidisciplinary approach involving endocrinologists, sleep specialists, and neurologists. Treatment may involve lifestyle modifications, continuous positive airway pressure (CPAP) for OSA, medications for RLS and insomnia, and optimizing diabetes management to improve sleep quality and overall health outcomes.

Mustafa Karaagac (Author)
MD, Karaman Training and Research Hospital
https://orcid.org/0000-0001-5737-5880

  • Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov 1;157.

  • International Classifi cation of Sleep Disorders – Third Edition (ICSD-3) (Online) - American Academy of Sleep Medicine [Internet]. [cited 2023 Apr 8]. Available from: https://learn.aasm.org/Listing/ a1341000002XmRvAAK

  • Sun SY, Chen GH. Treatment of Circadian Rhythm Sleep–Wake Disorders. Curr Neuropharmacol [Internet]. 2022 May 5 [cited 2023 Apr 9];20(6):1022. Available from: /pmc/articles/PMC9886819/

  • Koopman ADM, Beulens JW, Dijkstra T, Pouwer F, Bremmer MA, Van Straten A, et al. Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta- Analysis. Journal of Clinical Endocrinology and Metabolism. 2020 Jan 8;105(3).

  • Chew M, Tan NYQ, Lamoureux E, Cheng CY, Wong TY, Sabanayagam C. The associations of objectively measured sleep duration and sleep disturbances with diabetic retinopathy. Diabetes Res Clin Pract. 2020 Jan 1;159.

  • Nefs G, Donga E, van Someren E, Bot M, Speight J, Pouwer F. Subjective sleep impairment in adults with type 1 or type 2 diabetes: Results from Diabetes MILES-The Netherlands. Diabetes Res Clin Pract. 2015 Sep 1;109(3):466–75.

  • Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Basta M, et al. Insomnia with short sleep duration and mortality: The Penn State cohort. Sleep. 2010 Sep 1;33(9):1159–64.

  • Jain A, Sharmab R, Yadavc N, Chaudhary P, Jainc G, Maanju M. Quality of life and its association with insomnia and clinical variables in type 2 diabetes. Journal of Egyptian Public Health Association. 2017 Mar 1;92(1):52–9.

  • Lou P, Qin Y, Zhang P, Chen P, Zhang L, Chang G, et al. Association of sleep quality and quality of life in type 2 diabetes mellitus: A cross-sectional study in China. Diabetes Res Clin Pract. 2015;107(1):69–76.

  • Chaput JP, Tremblay A. Sleeping habits predict the magnitude of fat loss in adults exposed to moderate caloric restriction. Obes Facts. 2012 Sep;5(4):561–6.

  • Itani O, Jike M, Watanabe N, Kaneita Y. Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Med [Internet]. 2017 Apr [cited 2023 May 19];32:246–56. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1389945716301381

  • Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 2010 Feb;33(2):414–20.

  • Kripke DF, Langer RD, Elliott JA, Klauber MR, Rex KM. Mortality related to actigraphic long and short sleep. Sleep Med. 2011 Jan;12(1):28–33.

  • Yoshikawa F, Shigiyama F, Ando Y, Miyagi M, Uchino H, Hirose T, et al. Chronotherapeutic effi cacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia. Diabetes Res Clin Pract. 2020 Nov 1;169.

  • Zisapel N, Garfi nkel, Zorin, Wainstein J, Matas, Zisapel N. Effi cacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study. Diabetes Metab Syndr Obes. 2011 Aug;307.

  • Tsunoda T, Yamada M, Akiyama T, Minami T, Yoshii T, Kondo Y, et al. The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial. J Clin Med Res. 2016;8(12):878–87.

  • Doosti-Irani A, Ostadmohammadi V, Mirhosseini N, Mansournia M, Reiter RJ, Kashanian M, et al. The Effects of Melatonin Supplementation on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Hormone and Metabolic Research. 2018;50(11):783–90.

  • Kothari V, Cardona Z, Chirakalwasan N, Anothaisintawee T, Reutrakul S. Sleep interventions and glucose metabolism: systematic review and meta-analysis. Sleep Med. 2021 Feb 1;78:24–35.

  • Kothari V, Cardona Z, Chirakalwasan N, Anothaisintawee T, Reutrakul S. Sleep interventions and glucose metabolism: systematic review and meta-analysis. Sleep Med. 2021 Feb 1;78:24–35.

  • Alshehri MM, Alenazi AM, Alothman SA, Rucker JL, Phadnis MA, Miles JM, et al. Using Cognitive Behavioral Therapy for Insomnia in People with Type 2 Diabetes, Pilot RCT Part I: Sleep and Concomitant Symptom. Behavioral Sleep Medicine. 2021;19(5):652–71.

  • Tannas C. Type 2 Diabetes And Insomnia: Impact On Metabolic Control. Wayne State University Dissertations [Internet]. 2012 Jan 1 [cited 2023 May 12]; Available from: https://digitalcommons.wayne.edu/ oa_dissertations/624

  • Reutrakul S, Mokhlesi B. Obstructive Sleep Apnea and Diabetes: A State of the Art Review. Chest. 2017 Nov 1;152(5):1070–86.

  • Kent BD, McNicholas WT, Ryan S. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. J Thorac Dis. 2015;7(8):1343–57.

  • Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. Sleep Med Rev. 2016 Dec 1;30:11–24.

  • Grimaldi D, Beccuti G, Touma C, Van Cauter E, Mokhlesi B. Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: Therapeutic implications. Diabetes Care. 2014 Feb;37(2):355–63.

  • West SD, Groves DC, Lipinski HJ, Nicoll DJ, Mason RH, Scanlon PH, et al. The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabetic Medicine. 2010;27(4):423–30.

  • Tahrani AA, Ali A, Raymond NT, Begum S, Dubb K, Altaf Q, et al. Obstructive sleep apnea and diabetic nephropathy: A cohort study. Diabetes Care. 2013 Nov;36(11):3718–25.

  • Tahrani AA, Ali A, Raymond NT, Begum S, Dubb K, Mughal S, et al. Obstructive sleep apnea and diabetic neuropathy: A novel association in patients with type 2 diabetes. Am J Respir Crit Care Med. 2012 Sep 1;186(5):434–41.

  • Seicean S, Strohl KP, Seicean A, Gibby C, Marwick TH. Sleep disordered breathing as a risk of cardiac events in subjects with diabetes mellitus and normal exercise echocardiographic fi ndings. American Journal of Cardiology. 2013 Apr 15;111(8):1214–20.

  • Labarca G, Dreyse J, Salas C, Schmidt A, Rivera F, Letelier F, et al. Risk of mortality among patients with moderate to severe obstructive sleep apnea and diabetes mellitus: results from the SantOSA cohort. Sleep and Breathing. 2021 Sep 1;25(3):1467–75.

  • Lam JC, Lam B, Yao TJ, al. et. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J. 2010;35:138–45.

  • Salord N, Fortuna AM, Monasterio C, al. et. A randomized controlled trial of continuous positive airway pressure on glucose tolerance in obese patients with obstructive sleep apnea. Sleep. 2016;39:35–41.

  • Chirinos JA, Gurubhagavatula I, Teff K, al. et. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370:2265–75.

  • Pamidi S, Wroblewski K, Stepien M, al. et. Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial. Am J Respir Crit Care Med. 2015;192:96–105.

  • Weinstock TG, Wang X, Rueschman M, al. et. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012;35:617-625B.

  • Myhill PC, Davis WA, Peters KE, al. et. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocrinol Metab. 2012;97:4212–8.

  • Shaw JE, Punjabi NM, Wilding JP, al. et. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008;81:2–12.

  • Mokhlesi B, Grimaldi D, Beccuti G, al. et. Effect of one week of CPAP treatment of obstructive sleep apnoea on 24-hour profi les of glucose, insulin and counter-regulatory hormones in type 2 diabetes. Diabetes Obes Metab. 2017;19:452–6.

  • Martinez-Ceron E, Barquiel B, Bezos AM, Casitas R, Galera R, Garcia-Benito C, et al. Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes a randomized clinical trial. Am J Respir Crit Care Med. 2016 Aug 15;194(4):476–85.

  • West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. thorax.bmj.com [Internet]. 2007 [cited 2023 May 7];62:969–74. Available from: https://thorax.bmj.com/content/62/11/969.short

  • Morariu EM, Chasens ER, Strollo PJ, Korytkowski M. Effect of continuous positive airway pressure (CPAP) on glycemic control and variability in type 2 diabetes. Sleep and Breathing. 2017 Mar 1;21(1):145–7.

  • Lam JCM, Lai AYK, Tam TCC, Yuen MMA, Lam KSL, Ip MSM. CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure. Sleep and Breathing. 2017 May 1;21(2):377–86.

  • Foster G, Borradaile K, … MSA of internal, 2009 undefi ned. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. jamanetwork. com [Internet]. [cited 2023 May 7]; Available from: https://jamanetwork.com/journals/jamainternalmedicine/ article-abstract/224770

  • Blackman A, Foster G, … GZI journal of, 2016 undefi ned. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. nature.com [Internet]. [cited 2023 May 7]; Available from: https://www.nature.com/articles/ijo201652

  • Baslas V, Chand P, Jurel SK, Tripathi S, Arya D, Tripathi S, et al. A Pilot Study to Determine the Effect of Three Months of Oral Appliance Therapy using a Mandibular Advancement Device on HbA1c in Subjects with Type 2 Diabetes Mellitus and Obstructive Sleep Apnea. Journal of Prosthodontics. 2019 Mar 1;28(3):271–5.

  • Montagna P, Hornyak M, Ulfberg J, Hong SB, Koester J, Crespi G, et al. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood. Sleep Med. 2011 Jan;12(1):34–40.

  • Panossian LA, Avidan AY. Review of Sleep Disorders. Medical Clinics of North America. 2009 Mar;93(2):407–25.

  • Cho YW, Na GY, Lim JG, Kim SH, Kim HS, Earley CJ, et al. Prevalence and clinical characteristics of restless legs syndrome in diabetic peripheral neuropathy: Comparison with chronic osteoarthritis. Sleep Med. 2013 Dec;14(12):1387–92.

  • Cuellar NG, Ratcliffe SJ. A comparison of glycemic control, sleep, fatigue, and depression in type 2 diabetes with and without restless legs syndrome. Journal of Clinical Sleep Medicine. 2008 Feb 15;4(1):50–6.

  • Harashima SI, Nishimura A, Osugi T, Wang Y, Liu Y, Takayama H, et al. Restless legs syndrome in patients with type 2 diabetes: Effectiveness of pramipexole therapy. BMJ Support Palliat Care. 2016;6(1):89– 93.

  • Lopes LA, Lins CDMM, Adeodato VG, Quental DP, De Bruin PFC, Montenegro RM, et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care. 2005;28(11):2633–6.

  • Merlino G, Fratticci L, Valente M, Del Giudice A, Noacco C, Dolso P, et al. Association of restless leqs syndrome in type 2 diabetes: A case-control study. Sleep. 2007 Jul 1;30(7):866–71.

  • Modarresnia L, Golgiri F, Madani NH, Emami Z, Tanha K. Restless Legs Syndrome in Iranian People With Type 2 Diabetes Mellitus: The Role in Quality of Life and Quality of Sleep. Journal of Clinical Sleep Medicine. 2018 Feb 15;14(2):223–8.

  • Skomro RP, Ludwig S, Salamon E, Kryger MH. Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Med. 2001;2(5):417–22.

  • Zobeiri M, Shokoohi A. Restless Leg Syndrome in Diabetics Compared with Normal Controls. Sleep Disord. 2014;2014:1–4.

  • Bener A, Al-Hamaq AbdullaOAA, Ağan A, Öztürk M, Ömer A. The prevalence of restless legs syndrome and comorbid condition among patient with type 2 diabetic mellitus visiting primary healthcare. J Family Med Prim Care. 2019;8(12):3814.

  • Merlino G, Valente M, Serafi ni A, Fratticci L, Del Giudice A, Piani A, et al. Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes. Diabetes Educator. 2010 Jan;36(1):79–87.

  • Aurora RN, Kristo DA, Bista SR, Rowley JA, Zak RS, Casey KR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults - An update for 2012: Practice parameters with an evidence-based systematic review and meta-analyses. Sleep. 2012 Aug 1;35(8):1039–62.

  • Rizzi M, Barrella M, Kotzalidis GD, Bevilacqua M. Periodic Limbic Movement Disorder during Sleep as Diabetes-Related Syndrome? A Polysomnographic Study. ISRN Endocrinol. 2011 Aug 7;2011:1–5.

  • Kwatra V, Khan MA, Quadri SA, Cook TS. Differential Diagnosis and Treatment of Restless Legs Syndrome: A Literature Review. Cureus. 2018 Sep 14;

  • Monzon A, McDonough R, Meltzer LJ, Patton SR. Sleep and type 1 diabetes in children and adolescents: Proposed theoretical model and clinical implications. Pediatr Diabetes. 2019 Feb 1;20(1):78–85.

  • Chasens ER, Korytkowski M, Sereika SM, Burke LE. Effect of Poor Sleep Quality and Excessive Daytime Sleepiness on Factors Associated With Diabetes Self-Management. Diabetes Educ. 2013;39(1):74–82.

  • Nefs GM, Bazelmans E, Donga E, Tack CJ, de Galan BE. Sweet dreams or bitter nightmare: a narrative review of 25 years of research on the role of sleep in diabetes and the contributions of behavioural science. Diabetic Medicine. 2020 Mar 1;37(3):418–26.

  • Schipper SBJ, Van Veen MM, Elders PJM, van Straten A, Van Der Werf YD, Knutson KL, et al. Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature. Diabetologia. 2021 Nov 1;64(11):2367–77.

  • Manodpitipong A, Saetung S, Nimitphong H, Siwasaranond N, Wongphan T, Sornsiriwong C, et al. Nightshift work is associated with poorer glycaemic control in patients with type 2 diabetes. J Sleep Res. 2017 Dec 1;26(6):764–72.

  • Jørgensen JT, Karlsen S, Stayner L, Hansen J, Andersen ZJ. Shift work and overall and cause-specifi c mortality in the Danish nurse cohort. Scand J Work Environ Health. 2017;43(2):117–26.

  • Brouwer A, van Raalte DH, Nguyen HT, Rutters F, van de Ven PM, Elders PJM, et al. Effects of light therapy on mood and insulin sensitivity in patients with type 2 diabetes and depression: Results from a randomized placebo-controlled trial. Diabetes Care. 2019 Apr 1;42(4):529–38.

onix_3.0::thothThoth ONIX 3.0
onix_3.0::project_museProject MUSE ONIX 3.0
onix_3.0::oapenOAPEN ONIX 3.0
onix_3.0::jstorJSTOR ONIX 3.0
onix_3.0::google_booksGoogle Books ONIX 3.0
onix_3.0::overdriveOverDrive ONIX 3.0
onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
csv::thothThoth CSV
json::thothThoth JSON
kbart::oclcOCLC KBART
bibtex::thothThoth BibTeX
doideposit::crossrefCrossRef DOI deposit
onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
marc21record::thothThoth MARC 21 Record
marc21markup::thothThoth MARC 21 Markup
marc21xml::thothThoth MARC 21 XML

Share This Chapter!